InnovAge Holding Future Growth
Future criteria checks 4/6
InnovAge Holding is forecast to grow earnings and revenue by 123.8% and 6.6% per annum respectively. EPS is expected to grow by 123.8% per annum. Return on equity is forecast to be 23% in 3 years.
Key information
123.8%
Earnings growth rate
123.77%
EPS growth rate
| Healthcare earnings growth | 19.0% |
| Revenue growth rate | 6.6% |
| Future return on equity | 23.05% |
| Analyst coverage | Low |
| Last updated | 01 Jun 2026 |
Recent future growth updates
Analysis Article • Feb 06
Earnings Beat: InnovAge Holding Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
InnovAge Holding Corp. ( NASDAQ:INNV ) investors will be delighted, with the company turning in some strong numbers...Analysis Article • Nov 07
InnovAge Holding Corp. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
As you might know, InnovAge Holding Corp. ( NASDAQ:INNV ) just kicked off its latest quarterly results with some very...Recent updates
Narrative Update • May 16
INNV: Updated Modeling And 2026 Guidance Will Shape Balanced Risk Reward Outlook
Analysts have raised their price target on InnovAge Holding to $7 from $5, reflecting updated modeling related to fair value, discount rate, growth expectations, profit margins, and future P/E assumptions. Analyst Commentary JPMorgan raised its price target on InnovAge Holding to US$7 from US$5 after updating its model, while maintaining an Underweight rating on the stock.Narrative Update • Apr 20
INNV: Updated Modeling And 2026 Guidance Will Likely Limit Future Share Upside
Analysts raised their price target on InnovAge Holding to $7 from $5, citing updated company modeling as the key driver of the change. Analyst Commentary The move to a US$7 price target signals that at least one major firm sees enough change in the underlying assumptions to justify a higher valuation for InnovAge Holding, even while keeping a cautious stance on the stock.Narrative Update • Apr 05
INNV: Updated Modeling And 2026 Guidance Will Likely Temper Upside Expectations
Analysts have raised their price target on InnovAge Holding to $7 from $5, reflecting updated modeling assumptions that incorporate refined views on fair value, discount rate, revenue growth, profit margin, and future P/E. Analyst Commentary JPMorgan's updated price target signals a fresh look at InnovAge Holding's valuation framework, even as the firm maintains an Underweight stance.Narrative Update • Mar 22
INNV: Raised Outlook And Model Assumptions Will Likely Prove Overly Optimistic
Analysts have lifted their price target on InnovAge Holding to $7 from $5, reflecting updated models that refine assumptions around fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Bullish Takeaways Bullish analysts view the lift in the price target to $7 as a sign that updated assumptions on fair value and discount rates support a higher implied equity valuation.Narrative Update • Mar 08
INNV: Raised Outlook And P/E Assumptions Will Likely Prove Overly Optimistic
Analysts have lifted their price target on InnovAge Holding to $7 from $5, reflecting updated modeling assumptions around fair value, discount rate, revenue growth, profit margin and future P/E that collectively support a modestly higher valuation framework. Analyst Commentary Bullish Takeaways Bullish analysts see the move to a US$7 price target as recognition that updated fair value work supports a somewhat higher valuation range than before.Seeking Alpha • Feb 23
InnovAge: The Headwinds Are Priced In, The Growth May Not Be
Summary InnovAge Holding Corp. delivers strong operational execution, driving significant revenue and margin expansion through its PACE model for elderly care. INNV’s revenue rose 14.7% year-over-year, fueled by participant growth and capitation rate adjustments across established centers. Disciplined cost management and SG&A reductions have expanded center-level contribution margin to 22% and adjusted EBITDA margin to 9.2%. Despite Medicaid eligibility headwinds, INNV’s improved processes and in-house pharmacy transition support a bullish outlook on sustainability and leverage. Read the full article on Seeking AlphaNarrative Update • Feb 21
INNV: Future Margin Assumptions Will Likely Prove Overly Optimistic
Analysts have revised their price target on InnovAge Holding, reflecting updated views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. Together, these factors result in a new target of $7.00, up from $5.00.Analysis Article • Feb 06
Earnings Beat: InnovAge Holding Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
InnovAge Holding Corp. ( NASDAQ:INNV ) investors will be delighted, with the company turning in some strong numbers...Analysis Article • Jan 17
InnovAge Holding Corp.'s (NASDAQ:INNV) Price In Tune With Revenues
It's not a stretch to say that InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 0.9x right...Analysis Article • Dec 13
InnovAge Holding (NASDAQ:INNV) Might Be Having Difficulty Using Its Capital Effectively
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...Analysis Article • Nov 07
InnovAge Holding Corp. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
As you might know, InnovAge Holding Corp. ( NASDAQ:INNV ) just kicked off its latest quarterly results with some very...Analysis Article • Nov 03
Is InnovAge Holding (NASDAQ:INNV) A Risky Investment?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analysis Article • Sep 10
Improved Revenues Required Before InnovAge Holding Corp. (NASDAQ:INNV) Stock's 32% Jump Looks Justified
InnovAge Holding Corp. ( NASDAQ:INNV ) shareholders would be excited to see that the share price has had a great month...Analysis Article • Jul 08
Health Check: How Prudently Does InnovAge Holding (NASDAQ:INNV) Use Debt?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...New Narrative • May 29
Expanding US Senior Care Integration Will Drive Healthcare Transformation
Enrollment growth and efficient geographic expansion are positioning the company for sustained revenue gains and scalable growth.Analysis Article • May 09
After Leaping 36% InnovAge Holding Corp. (NASDAQ:INNV) Shares Are Not Flying Under The Radar
InnovAge Holding Corp. ( NASDAQ:INNV ) shares have had a really impressive month, gaining 36% after a shaky period...Analysis Article • Apr 09
Is InnovAge Holding (NASDAQ:INNV) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Analysis Article • Feb 06
Investors Aren't Entirely Convinced By InnovAge Holding Corp.'s (NASDAQ:INNV) Revenues
InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 0.6x may look like a pretty appealing...Analysis Article • Nov 07
Investors Aren't Entirely Convinced By InnovAge Holding Corp.'s (NASDAQ:INNV) Revenues
It's not a stretch to say that InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 1.1x seems...Analysis Article • Aug 20
Is InnovAge Holding (NASDAQ:INNV) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analysis Article • Jun 28
InnovAge Holding Corp.'s (NASDAQ:INNV) Shares Leap 30% Yet They're Still Not Telling The Full Story
InnovAge Holding Corp. ( NASDAQ:INNV ) shares have had a really impressive month, gaining 30% after a shaky period...Analysis Article • May 07
Sentiment Still Eluding InnovAge Holding Corp. (NASDAQ:INNV)
It's not a stretch to say that InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 0.8x right...Analysis Article • Mar 15
InnovAge Holding (NASDAQ:INNV) Has Debt But No Earnings; Should You Worry?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analysis Article • Jan 06
Market Still Lacking Some Conviction On InnovAge Holding Corp. (NASDAQ:INNV)
There wouldn't be many who think InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 1.1x is...Analysis Article • Aug 10
InnovAge Holding Corp.'s (NASDAQ:INNV) Intrinsic Value Is Potentially 73% Above Its Share Price
Key Insights The projected fair value for InnovAge Holding is US$11.07 based on 2 Stage Free Cash Flow to Equity...Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2028 | 1,100 | 79 | 109 | 112 | 1 |
| 6/30/2027 | 1,034 | 57 | 87 | 92 | 3 |
| 6/30/2026 | 966 | -1 | 19 | 30 | 3 |
| 3/31/2026 | 949 | -12 | 43 | 52 | N/A |
| 12/31/2025 | 915 | 6 | 50 | 59 | N/A |
| 9/30/2025 | 885 | -17 | 36 | 44 | N/A |
| 6/30/2025 | 854 | -30 | 27 | 33 | N/A |
| 3/31/2025 | 832 | -31 | 16 | 26 | N/A |
| 12/31/2024 | 807 | -26 | -3 | 5 | N/A |
| 9/30/2024 | 787 | -16 | -19 | -11 | N/A |
| 6/30/2024 | 764 | -21 | -45 | -37 | N/A |
| 3/31/2024 | 741 | -31 | -34 | -26 | N/A |
| 12/31/2023 | 721 | -32 | -13 | 0 | N/A |
| 9/30/2023 | 699 | -38 | -44 | -26 | N/A |
| 6/30/2023 | 688 | -41 | -3 | 20 | N/A |
| 3/31/2023 | 684 | -42 | -26 | 10 | N/A |
| 12/31/2022 | 689 | -38 | -67 | -26 | N/A |
| 9/30/2022 | 697 | -27 | -23 | 20 | N/A |
| 6/30/2022 | 699 | -7 | -11 | 27 | N/A |
| 3/31/2022 | 697 | 13 | 9 | 34 | N/A |
| 12/31/2021 | 676 | 5 | 7 | 25 | N/A |
| 9/30/2021 | 658 | 13 | 13 | 31 | N/A |
| 6/30/2021 | 638 | -44 | -27 | -8 | N/A |
| 3/31/2021 | 619 | -38 | -12 | 7 | N/A |
| 12/31/2020 | 607 | -20 | 12 | 30 | N/A |
| 9/30/2020 | 585 | -26 | 6 | 19 | N/A |
| 6/30/2020 | 567 | 26 | 32 | 44 | N/A |
| 6/30/2019 | 466 | 20 | N/A | 26 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: INNV is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (3.5%).
Earnings vs Market: INNV is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: INNV is expected to become profitable in the next 3 years.
Revenue vs Market: INNV's revenue (6.6% per year) is forecast to grow slower than the US market (12.1% per year).
High Growth Revenue: INNV's revenue (6.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: INNV's Return on Equity is forecast to be high in 3 years time (23%)
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/03 18:57 |
| End of Day Share Price | 2026/06/03 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
InnovAge Holding Corp. is covered by 14 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vikram Kesavabhotla | Baird |
| Steven Valiquette | Barclays |
| Sarah James | Barclays |